Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
The American Surgeon|November 30, 2017
Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB MelanomaMoshim Kukar, Emmanuel Gabriel, Rebecca May, et al.
Plos One|September 7, 2012
Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancerSwati Kulkarni, Katarzyna Augoff, Louis Rivera, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 2018
Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resectionSai Yendamuri, Samjot Singh Dhillon, Adrienne Groman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2026
Long-term Analysis of One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 TrialAnurag K Singh, Mark K Farrugia, Kevin L Stephans, et al.
Cancer|May 31, 2013
Prognostic implications of signet ring cell histology in esophageal adenocarcinomaSai Yendamuri, Miriam Huang, Usha Malhotra, et al.
The Journal of Surgical Research|December 6, 2020
Approach to Resectable N1 Non-Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseChan Y Pu, Sarah Rodwin, Bre Nelson, et al.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Journal of Cancer Survivorship : Research and Practice|February 12, 2011
Structuring survivorship care: discipline-specific clinician perspectivesElizabeth A Gage, Megan Pailler, Michael A Zevon, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2019
One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 TrialAnurag K Singh, Jorge A Gomez-Suescun, Kevin L Stephans, et al.
Cureus|January 12, 2026
A Phase I Study of Nimotuzumab With Nivolumab in Advanced Non-small Cell Lung Cancer and Head and Neck Squamous Cell CancerSyed Ather Hussain, Mary E Reid, Rachel Frascati, et al.
Pageof 8